Harvard University granted Life Technologies exclusive development rights for characterization assays to assess human pluripotent stem cells for use in discovery and research. The assays, developed by Harvard associate professor Alex Meissner, will be offered in Life's semiconductor sequencing and PCR-based systems.
Harvard licenses stem cell assays to Life Technologies
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan